viewAnteris Technologies Ltd

Admedus Limited appoints Wayne Paterson as chairman


Specialist healthcare company Admedus Limited (ASX:AHZ) has appointed Wayne Paterson as non-executive chairman with immediate effect, following the resignation of Chris Catlow who held the position for five years.

Graeme Rowley, who served as a non-executive director for five years, has also resigned.

Catlow and Rowley had been involved with the group for the past 11 years.

Wayne Paterson, commented: “The board and I would like to thank Chris and Graeme for their work in establishing Admedus and their help in growing it into the diversified healthcare company it is today.

"Their contributions have been invaluable over the years."

Lee Rodne, CEO, added: “The Admedus board now consists of directors with extensive experience in each of our core product areas with specific backgrounds in sales, marketing, general management and corporate governance.

"We look forward to their ongoing input to our outstanding management team."


Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

Quick facts: Anteris Technologies Ltd

Price: 4 AUD

Market: ASX
Market Cap: $23.64 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...


Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read